Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03231345 · ClinicalTrials.gov registry record · NA

Ultrasound-guided Peripheral IJ Study

A NA study, sponsored by University Medical Center of Southern Nevada.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT03231345: Completed NA study, sponsored by University Medical Center of Southern Nevada.

NCT03231345 is a NA study that has completed, run by University Medical Center of Southern Nevada. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03231345, a NA study, has completed, sponsored by University Medical Center of Southern Nevada.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

Difficult venous access in some patients such as those with obesity, IV drug use, chronic illness, or vascular pathology often causes increased discomfort and delayed patient care due to multiple attempts to gain venous access. If access is achieved at all, it usually results in a much smaller catheter than needed to provide optimal care for the patient. Ultrasound-guided placement of a peripheral IV in the internal jugular vein is common in the investigators' emergency department and is gaining popularity across the US. This study investigates the utility and safety of placing an ultrasound-guided peripheral IV catheter in the internal jugular vein.

Primary Outcome

The primary study endpoint is successful cannulation vs failure to cannulate the internal jugular vein.

Interventions

  • DEVICE Ultrasound
  • PROCEDURE US guided IJ

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2016-08-18
Est. Completion 2018-05
Phase NA

What the finished NCT03231345 record still lists

NCT03231345 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.

NCT03231345 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03231345 about?

NCT03231345 is a clinical study titled "Ultrasound-guided Peripheral IJ Study". Difficult venous access in some patients such as those with obesity, IV drug use, chronic illness, or vascular pathology often causes increased discomfort and delayed patient care due to multiple attempts to gain venous access. If access is achieved at all, it usually results in a much smaller cathe...

What is the current status of trial NCT03231345?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-08-18. Estimated completion is 2018-05.

What interventions are being tested in trial NCT03231345?

The interventions under investigation include: Ultrasound (DEVICE), US guided IJ (PROCEDURE).

Who is sponsoring clinical trial NCT03231345?

This trial is sponsored by University Medical Center of Southern Nevada, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03231345's enrollment target sits among peer trials

35 1564th of 2000 higher than 431 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03231345, the US trial registry maintained by the National Library of Medicine. NCT03231345 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.